Articles on this page are updated by ProfileData Research on an hourly basis. To see the summary of the SENS notice, please click on the headline. To read the original SENS message, please click on the link in the summary.



Date Headline/Title
08 December 2015Report on Annual General Meeting Proceedings
01 December 2015Voluntary announcement - Aspen acquires the rights to Hydroxyprogesterone Caproate Injection (HPC)
19 November 2015Dealing in Aspen securities by the Company Secretary of Aspen
10 November 2015Dealing in securities by directors and by directors of a major subsidiary
03 November 2015No change statement and AGM notice
22 October 2015Dealing in Aspen securities by a director of Aspen
13 October 2015Dealing in Aspen securities by the Aspen Share Incentive Trust
09 October 2015Dealing in securities by directors company secretary and directors of a major subsidiary
02 October 2015Dealing in Aspen securities by a director of Aspen
25 September 2015Dealing in Aspen securities by a director of Aspen
09 September 2015Aspen final results June 2015
07 September 2015Aspens results for the year ended 30 June 2015 and year-end results presentations
28 August 2015Trading statement
12 August 2015Resignation as Directors and Chairman / Appointment of Chairman
11 August 2015Divestment of portfolio
05 August 2015Renewal of Cautionary Announcement- Possible Infant Nutritionals Business Acquisition
30 June 2015Changes in Aspens Black Economic Empowerment Shareholding
25 June 2015Renewal of Cautionary Announcement- Possible Infant Nutritionals Business Acquisition
21 May 2015Divestment of Portfolio of Branded and Generic Products to Strides Entities
14 May 2015Cautionary Announcement
11 May 2015Divestment of South African Business Unit to Litha
20 March 2015Notification in terms of Section 122(3) of The Companies Act and Section 3.83(b) of the JSE Listings Requirements
20 March 2015Resignation of independent non-executive director Mogammed Rafique Bagus
17 March 2015Dealing in securities by directors
13 March 2015GSK announces completion of the sale of half its stake in Aspen
05 March 2015Aspen interim results Decemeber 2014
26 February 2015Trading Statement
23 February 2015Aspen interim results release & presentation
23 January 2015ACQUISITION OF RIGHTS TO AN ANTI-COAGULENT PRODUCT FROM NOVARTIS
24 December 20142014 Anti-Retroviral Tender Results
10 December 2014Results of AGM
10 December 2014Changes to the Board
05 December 2014Directors Dealings
11 November 2014Clarification in Respect of Form of Proxy
31 October 2014Aspen Holdings Acquires Stake In Infant Milk Formula Production Facility In New Zealand
30 October 2014No change statement and notice of annual general meeting
23 October 2014Dealings in securities by directors company secretary and directors of a major subsidiary
20 October 2014Aspen to acquire license rights
09 October 2014Aspen to enter strategic collaboration with GlaxoSmithKline in Japan
26 September 2014Further announcement regarding the disposal of rights to commercialise fondaparinux products in the US
10 September 2014Aspen final results 30 June 2014
08 September 2014Year-end Results and Results Presentation
03 September 2014Pre-Closed Period Conference Call
29 August 2014Trading Statement
30 June 2014Appointment of Maureen Manyama-Matome as member of the Audit & Risk Committee
30 June 2014Response to media reports following pre-closed period conference call
27 June 2014Dealings by a Director of a Major Subsidiary
04 June 2014Dealings by a Director of a Major Subsidiary
20 May 2014Directors Dealings
19 May 2014Appointment of an Independent Non-Executive Director
31 March 2014Dealing in securities by a director of a major subsidiary
24 March 2014Directors Dealings
19 March 2014Dealing in securities by a director of a major subsidiary
06 March 2014Aspen interim result December 2013
21 February 2014Voluntary Trading Statement
31 December 2013Acquisition of a portfolio of products from MSD-All conditions precedent met
31 December 2013Further Announcement Relating To The Acquisition By Aspen Of The Glaxosmithkline Groups (Gsk) Arixtra And Fraxipa
31 December 2013Acquisition of a portfolio of products from MSD-All conditions precedent met
31 December 2013Further Announcement Relating To The Acquisition By Aspen Of The Glaxosmithkline Groups (Gsk) Arixtra And Fraxipa
20 December 2013Competition Tribunal approval
04 December 2013Directors Dealings
04 December 2013Results of AGM
20 November 2013Notification in terms of S122(3) of the Companies Act and S3.83(b) of the JSE Listings Requirements
19 November 2013Dealing in securities by Directors and by Directors of major subsidiaries
11 November 2013Results of Extraordinary General Meeting of Shareholders to approve proposed GSK Transaction
04 November 2013No change statement and AGM
31 October 2013Dealing in Aspen Securities by Directors of a major subsidiary
31 October 2013Acquisition from MSD
28 October 2013Completion of acquisition of Infant Nutritional businesses in Latin America from Nestle
24 October 2013Conclusion of arrangements in respect of acquisition finance facilities
18 October 2013Dealing in Aspen Securities by a Director of a major subsidiary
14 October 2013Dealing in Securities by Directors Company Secretary and Directors of a major subsidiary
14 October 2013Dealing in Securities by a Director and Directors of a major subsidiary
11 October 2013Directors Dealings
10 October 2013Posting of circular and notice of general meeting
01 October 2013Acquisition fr
01 October 2013Acquisition from MSD of an API manufacturing business and portfolio of products by Aspen: Conditions precedent met
30 September 2013Aspen -Acquisition by Aspen of GlaxoSmithKline plc
30 September 2013Acquisition by Aspen of GlaxoSmithKline plcs Arixtra and Fraxiparine/Fraxodi brands
13 September 2013US$2 035 000 000 and ZAR 7 330 000 000Acquisition Finance Facilities
13 September 2013Record Date
11 September 2013Aspen final results June 2013
05 September 2013Renewal of Cautionary
30 August 2013Trading Statement
07 August 2013Acquisition of Infant Nutritional businesses from Nestle - Voluntary Announcement
24 July 2013Renewal of Cautionary Announcement- Discussions with GSK
27 June 2013Signed agreeme
27 June 2013Signed agreements for acquisition and Renewal of Cautionary
18 June 2013Cautionary Announcement
03 June 2013Renewal of Cautionary Announcement - Discussions with MSD
23 April 2013Renewal of Cautionary Announcement
18 April 2013Acquisition of Infant Nutritional Businesses from Nestle
07 March 2013Aspen interim results 31 December 2012
21 February 2013Trading Statement
04 February 2013Cautionary announcement - discussions with MSD
04 February 2013Cautionary announcement - discussions with MSD
04 December 2012Aspen announce results of AGM
04 December 2012Directors Dealings
03 December 2012Completion acquisition
27 November 2012Dealing in securities by directors and by directors of a major subsidiary
23 November 2012Directors Dealings
05 November 2012Aspen change statement and notice of AGM
02 November 2012Directors Dealings
01 November 2012Directors dealings
05 October 2012Directors dealings
02 October 2012Directors Dealings
14 September 2012Dealing in securities by directors
12 September 2012Aspen final results June 2012
12 September 2012Aspen Year End Financial Results Press Release
12 September 2012Aspen Financial Results and Capital Distribution
05 September 2012Changes in BEE shareholding
30 August 2012Aspen anticipates higher earnings
15 August 2012Aspen acquisition announcement
08 June 2012Dealing in aspen securities by a
07 June 2012Aspen changes in BEE shareholding
07 June 2012Dealing in securities by director
02 May 2012Dealing in Aspen securities by a
25 April 2012Dealing in Aspen securities by a
20 April 2012Aspen announces Multi-Territory acquisition
26 March 2012Dealing in securities by director
09 March 2012Appointment of a non-executive director
07 March 2012Aspen interim results 31 December 2011
07 March 2012Aspen increases revenue by 31 percent
07 March 2012Unaudited interim financial
21 February 2012Aspen expects improved earnings
20 January 2012Dealings in securities by
01 December 2011Results of AGM
01 December 2011Response to Bloomberg report
02 November 2011No change statement and notice of AGM
13 October 2011Resignation of a director
23 September 2011Dealing in securities by
16 September 2011Dealing in securities by
13 September 2011Press release
13 September 2011Aspen final results June 2011
13 September 2011Press release
13 September 2011Aspen Pharmacare Holdings Limited (Aspen) - Reviewed preliminary
02 September 2011Aspen anticipating higher earnings
15 August 2011Appointment of company secretary
05 August 2011Resignation of company secretary
20 June 2011Dealing in securities by director of
12 April 2011Dealing in securities by director of
08 April 2011Dealing in securities by director of
11 March 2011Dealing in securities by director
04 March 2011Aspen appoints new company secretary
03 March 2011Revised press release
03 March 2011Aspen increases revenue
03 March 2011Aspen interim results December 2010
03 March 2011Aspen increases revenue by 33 percent
03 March 2011Unaudited interim financial results
14 January 2011Acquisition of Sigma
14 December 2010Aspen announce anti-retroviral tender results
26 November 2010All resolutions approved at AGM
23 November 2010Further Sigma announcement
03 November 2010No change statement and AGM
06 October 2010Dealing in securities by director
15 September 2010Aspen final results June 2010
15 September 2010Aspen`s revenue increases by 20 percent to exceed R10 billion
15 September 2010Aspen Pharmacare Holdings Ltd (Aspen) - Reviewed preliminary Group
23 August 2010Aspen expects higher earnings
16 August 2010Sigma acquisition and caution withdrawn
12 July 2010Aspen further announcement
07 July 2010Renewal of cautionary
21 May 2010Detailed cautionary announcement
23 March 2010In compliance with Rules 3.63 - 3.74 of the JSE Listing
18 March 2010Voluntary announcement not a Trading
18 March 2010Trading update
03 March 2010Aspen interim results 31 December 2009
03 March 2010Aspen raises profits by 31% as South African business shines
03 March 2010Interim financial results for the
12 February 2010Trading update
11 December 2009Appointment Of Director
04 December 2009Results Of Annual General Meeting
01 December 2009Completion of multiple strategic inter
03 November 2009Completion Of Multiple Strategic Inter - Dependant Transactions
03 November 2009Change Statement And Notice Of Annual General Meeting
21 October 2009Directors Dealings
22 September 2009Directors dealings
08 September 2009Aspen final results June 09
08 September 2009Aspen`s revenue increases by 80
08 September 2009Aspen Holdings - Reviewed preliminary Group financial results for the year
01 September 2009Trading Update
29 June 2009Director`s Dealings
24 June 2009Director Dealings in shares
24 June 2009Dealings in Securities
12 June 2009Official Statement Regarding the Alleged
12 May 2009Aspen and GSK agree on multiple
26 March 2009Renewal of cautionary announcement
05 March 2009Aspen interim results December 08
05 March 2009Aspen`s Offshore Operations Drive An Impressive 91% Revenue Increase
05 March 2009Interim Financial Results For The Six Months Ended 31 December
02 March 2009Resignation of non-executive director
19 February 2009Renewal Of Cautionary Announcement
12 February 2009Trading update
30 January 2009Servier And Aspen Sign Technology Transfer Mou
13 January 2009Cautionary announcement
13 January 2009Cautionary announcement
10 December 2008Director`s dealings
03 December 2008Dealings in securities
03 December 2008Director`s dealings
28 November 2008Results Of Annual General Meeting
07 November 2008Posting Of Annual Report And Notice Of Annual General Meeting
29 October 2008Director`s Dealings
24 October 2008Directors` Dealings
16 October 2008Finalisation Of Term Loan Funding Facility
09 October 2008Voluntary Transaction Announcement
03 October 2008Director`s dealings
16 September 2008Aspen final results June 08
16 September 2008Aspen establishes its international platform for future growth
16 September 2008Aspen Holdings - Reviewed preliminary Group financial results for the
16 September 2008Revision Of Terms Of Aspen`s Investment In Strides` Latin American
26 August 2008New appointment to the board of
23 July 2008Aspen businesses in licensing deal with GSK
16 July 2008Withdrawal Of Cautionary Announcement
30 June 2008Worldwide acquisition of brands by
26 June 2008Anti-Retroviral Tender Results
06 June 2008Cautionary announcement
23 May 2008Director
14 May 2008Director
05 May 2008Voluntary announ
31 March 2008Company announcement - Directorate
25 February 2008Aspen interim results December 07
25 February 2008Aspen records 15% year-on-year revenue increase
25 February 2008ASPEN - Unaudited interim financial results for the six months ended 31
20 February 2008Change in directorate
20 November 2007Transact
20 November 2007Aspen Pharmacare Holding Limited - Press Rel
20 November 2007Transact
16 November 2007Results
16 November 2007Cautiona
06 November 2007Dealings
11 October 2007Posting of annual report and notice
19 September 2007Dealing In Secur
20 August 2007Capital Distribution
20 August 2007Aspen final results June 07
20 August 2007Press re
20 August 2007Reviewed preliminary group financial
22 June 2007Dealing
11 June 2007Dr Judy Dlamini Appointed Chairman D
08 June 2007Director`s Dealings
04 June 2007Director
24 April 2007Key Arv Products Viread* And Truvada
23 April 2007Dealings In Securities
19 April 2007Directors Dealin
04 April 2007Tibotec and Aspen Collaborate on Pre
26 February 2007Aspen interim results December 06
26 February 2007Press Re
26 February 2007Interim financial results: six month
15 February 2007Appointment of alternate director
12 February 2007Trading
19 January 2007Aspen And Lupin Decide Not To Progre
16 November 2006Results of Ann
11 October 2006Posting Of Annual Report And Notice Of Ann
05 September 2006Appointment of
30 August 2006Dealing in sha
21 August 2006Aspen final results June 06
21 August 2006Press Release
21 August 2006Aspen-Reviewed Preliminary Group Financial Results
19 July 2006Trading Statem
15 June 2006Withdrawal Of
31 May 2006Cautionary ann
16 May 2006Aspen to manufacture influenza medicine
08 May 2006Resignation Of Director
20 March 2006Dealing in shares by a director of a major
09 March 2006Dealings in se
27 February 2006Aspen Signs MO
27 February 2006Aspen interim results December 05
27 February 2006Press Release
27 February 2006Interim financial results for the six mont
23 February 2006Appointment of
16 February 2006Aspen and BMS conclude strategic ARV deal
09 February 2006TRADING STATEM
09 January 2006Directorate
25 November 2005Director Deali
08 November 2005Dealing in Aspen Pharmacare Holdings Limit
07 November 2005Announcement
26 October 2005Results Of Ann
03 October 2005Dealing in shares by a director of a subsi
03 October 2005Dealing in shares by a director of a subsi
03 October 2005No change statement and notice of annual g
03 October 2005No change statement and notice of annual g
26 September 2005Aspen And Lupin Sign TB Deal
23 September 2005Aspen and Indias Matrix sign JVs
13 September 2005Director dealings in shares
26 August 2005Aspen Pharmacare Holdings Limited
22 August 2005Aspen Pharmacare Holdings Ltd - Press release
22 August 2005Aspen final results June 05
27 July 2005Clarification
21 July 2005Trading Statem
21 July 2005Trading Statem
19 July 2005MSD grants Aspen generic ARV license
19 July 2005MSD grants Aspen generic ARV license
15 July 2005Appointment Of Director
21 June 2005Aspen Pharmacare Holdings Ltd - Director dealing i
20 June 2005Dealing In Shares By A Director
15 June 2005Scheme Of Arrangement
15 June 2005Scheme Of Arrangement
15 June 2005Directors Dealings
07 June 2005Sanctioning by the high court of the Aspen
30 May 2005Results Of The Aspen General And Scheme Meetings
30 May 2005Results Of The Aspen General And Scheme Meetings
06 May 2005Order Of Court
06 May 2005Salient Dates In Respect Of The Proposed S
06 May 2005Salient Dates In Respect Of The Proposed S
25 April 2005Aspen and US-based Gilead
25 April 2005Aspen and US-based Gilead
20 April 2005Dealing In Shares By A Director
08 April 2005Aspen signs MOU with Indian based Matrix
17 March 2005Proposed Introduction Of Additional Black
17 March 2005Proposed Introduction Of Additional Black
04 March 2005Aspen awarded
04 March 2005Aspen awarded
21 February 2005Interim financial results for the six months ende
21 February 2005Aspen interim results December 04
15 February 2005BLACK ECONOMIC EMPOWERMENT (BEE) TRANSACTION
01 February 2005TRADING STATEMENT
28 January 2005Aspen shares continue to surge
25 January 2005ADDRESS BY STEPHEN SAAD, ASPEN PHARMACARE
14 December 2004Withdrawal of cautionary announcement
14 December 2004Withdrawal of cautionary announcement
13 December 2004Aspen To Supply Us Government With Generic ARVs
13 December 2004Aspen To Supply Us Government With Generic ARVs
22 November 2004RENEWAL OF CAUTIONARY ANNOUNCEMENT
22 November 2004RENEWAL OF CAUTIONARY ANNOUNCEMENT
18 November 2004DEALINGS IN SECURITIES
16 November 2004Aspen chief enjoys 55% pay rise after good results
05 October 2004Renewal of cautionary announcement
01 October 2004NO CHANGE STATEMENT AND NOTICE OF AGM
08 September 2004Aspen To Supply US Government
08 September 2004Aspen To Supply US Government
18 August 2004Financial Results For The Year Ended 30 June 04
18 August 2004Aspen results for the year ended 30 June 04
10 August 2004APPOINTMENT OF EXECUTIVE DIRECTOR
10 August 2004APPOINTMENT OF EXECUTIVE DIRECTOR
29 July 2004Announcement
29 July 2004Announcement
27 July 2004Results Of General Meeting
13 July 2004ACQUISITION OF FINE CHEMICALS
13 July 2004Trading statement and cautionary announcement
24 June 2004Proposed Specific Share Repurchase
24 June 2004Proposed Specific Share Repurchase
15 June 2004Aspen enters the infant nutritional market
13 May 2004Resignation Of Chief Operating Officer
13 May 2004Resignation Of Chief Operating Officer
06 May 2004CAUTIONARY ANNOUNCEMENT
10 March 2004Acquisition By Aspen Of Fine Chemicals
03 March 2004Dealing In Securities By Director
17 February 2004Aspen results for the 6 months ended 31 Dec 03
17 February 2004INTERIM RESULTS AND WITHDRAWAL OF CAUTIONARY
05 February 2004News release
15 January 2004TRADING STATEM
15 January 2004TRADING STATEM
14 November 2003RESULTS OF GENERAL MEETING
24 October 2003Aspen to manuf
24 October 2003Aspen to manuf
01 October 2003ASPEN - DIRECTORS DEALINGS
23 September 2003Changes to the Board
25 August 2003Directors dealing
20 August 2003Aspen results for the year ended 30 June 03
14 August 2003Aspen gains from state AIDS plan
06 August 2003Aspen manufactures Africas first generic ARVs
06 May 2003Aspen Pharmacare - press release
26 March 2003Aspen arrangemnt with GlaxoSmithKline
26 March 2003Aspen Pharmacare to distribute 40 GlaxoSmithKline
12 March 2003PHARMACARE HOLDINGS LIMITED
17 February 2003Aspen results for 6 months ended 31 Dec 02
13 December 2002Aspen/Peu - Announcement
20 November 2002Directors Deal
30 October 2002PRESS RELEASE
29 October 2002Aspen Pharmacare Holdings Limited - Dealing in Se
25 October 2002Directors dealing
21 October 2002Directors deal
17 October 2002Aspen Pharmacare - Directors Dealing
15 October 2002Aspen Pharmacare - Press Release
15 October 2002Aspen Pharmacare - Press Release
21 August 2002Aspen results for the 12 months ended 30 Jun 02
31 May 2002Change In Directorate
22 April 2002Aspen to benefit from States new AIDS stance
20 March 2002Directors Deal
07 March 2002Aspen in Novartis deal
19 February 2002Directors Dealing
12 February 2002Aspen results for 6 months ended 31 Dec 01
31 January 2002Acquisition By Ceppwawu Pharmaceutical Investments
31 January 2002Dealing In Shares By Directors
20 November 2001Directors Disclosure
08 October 2001Aspen receives rights to Aids drugs from GSK
27 September 2001Aspen Pharmacare & Merck Generics (rsa) - Enter In
24 August 2001Purchase Of Sh
22 August 2001Aspen results for 12 months ended 30 Jun 01
17 August 2001Changes To The
18 July 2001Aspen Company Announcement
04 July 2001Press Release
18 June 2001Aspen Strate take on
21 May 2001Aspen in deal with Tibett & Britten
30 March 2001Aspen share repurchase
07 March 2001Dealing In Sha
15 February 2001Aspen results for 6 months ended 31 Dec 00
21 December 2000Aspen acquires Co-Pharma
12 December 2000Aspen AFSs qualified
12 December 2000Aspen response to qualification of AFSs
14 September 2000Aspen results for 12 months ended 30 Jun 00
20 June 2000Aspen subsidiaries make various disposals
17 February 2000Aspen results for 6 months ended 31 Dec 99
17 February 2000Results of general meeting
27 January 2000Aspen to change name
25 October 1999Aspen disposes of Lagap Pharmaceuticals
27 September 1999Aspen releases finals for 30 June 99
21 September 1999Aspen issues cautionary
25 June 1999Aspen acquires own shares & reduces share premium
23 March 1999Aspen finalises proposals regarding SAD
10 March 1999Aspen consortium nears agreement with SAD
16 February 1999Aspen makes offer 4 SAD pharmaceutical business
12 February 1999Aspen issues cautionary
01 February 1999Aspen acquires Columbia Pharmaceuticals
29 January 1999Aspen makes a minority offer
12 August 1998Medhold has acquired Aspen Health Care and Attwell
14 July 1998Medhold has acquired Aspen Health Care and Attwell
03 July 1998Further cautionary
15 May 1998Further cautionary
24 March 1998Cautionary announcement
04 November 19961:2 consolidation during period to April 1995
Powered by ProfileData